
Healthtech funding rebounds to $1.1 billion in Q3 as investors return to diagnostics
Late-stage rounds are back, but investors are writing cheques for profitability, not growth at any cost.
6 min read
Startups & Funding Editor
Rohan follows the money in Indian healthcare: venture rounds, acquisitions, IPOs and the founders behind them.
Tracks 600+ Indian healthtech companies

Late-stage rounds are back, but investors are writing cheques for profitability, not growth at any cost.
6 min read

The co-founders explain why they designed for affordability first and how they convinced cardiologists to trust the data.
7 min read

The lab chain cut walk-in centres by a third and says home visits now drive 60% of revenue.
5 min read

The deals give the company more than 30,000 clinic customers and set up a likely IPO filing next year.
8 min read

The diabetes and hypertension platform says adherence data could help insurers price outpatient cover.
5 min read

The Series B will fund regulatory filings and a push into district hospitals where neurologists are scarce.
6 min read

High customer-acquisition costs are pushing app makers towards enterprise contracts.
8 min read

From AI pathology to rural pharmacies, our editors pick the young companies with the most momentum.
7 min read